TLX Competitors & Alternatives
Compare Telix Pharmaceuticals Limited with similar stocks in the same industry
Biotechnology
TLX
Main Stock$8.99
-2.65%
Tradestie Score
58
Market Cap
$3.40B
P/E Ratio
93.6
Revenue Growth
22.3%
Analyst Upside
+120.9%
Top Competitors
214 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
QURE
uniQure N.V.
|
$22.02
-7.52%
|
$3.39B | - | 51 | Compare |
|
SRRK
Scholar Rock Holding Corporation Common Stock
|
$43.21
+0.01%
|
$3.33B | - | 56 | Compare |
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$19.76
-1.89%
|
$3.31B | - | 49 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
+0.04%
|
$3.20B | 27.5 | 48 | Compare |
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$14.79
-3.52%
|
$3.09B | - | 59 | Compare |
|
VKTX
Viking Therapeutics, Inc
|
$26.89
-7.99%
|
$3.08B | - | 39 | Compare |
|
CNTA
Centessa Pharmaceuticals plc American Depositary Shares
|
$40.50
+0.80%
|
$3.03B | - | 48 | Compare |
|
XENE
Xenon Pharmaceuticals Inc
|
$39.66
-2.03%
|
$3.02B | - | 33 | Compare |
|
CGON
CG Oncology, Inc. Common stock
|
$84.95
+14.17%
|
$3.01B | - | 34 | Compare |
|
APLS
Apellis Pharmaceuticals, Inc. Common Stock
|
$41.03
-0.07%
|
$2.92B | 38.3 | 50 | Compare |
More TLX Analysis
Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)
214 stocks in this industry